Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://carlyplth230167.get-blogging.com/39489243/trelaglutide-exploring-a-new-option-for-chronic-diseases